Forgiving lens

Ophtec BV has received a CE mark for a new aspheric presbyopia correcting intraocular lens (IOL), Precizon Presbyopic, with a patent-pending continuous transitional focus (CTF) optical design.
“The new CTF optic seems to offer a safer surgical approach than traditional multifocal technologies available on the market, and addresses the fact that nature is not an optical bench and IOL seating is important for good performance,” said a company spokesman.
“The technology offers a full range of vision and, due to the CTF’s transitional zones, a smooth, continuous transition from near vision to infinity is achieved. Consequently, CTF ensures a more 'forgiving' lens that enables surgeons to treat a wider range of presbyopic patients with a higher degree of confidence,” he said.
Precizon Presbyopic will be commercially launched in October during the XXXV Congress of the ESCRS in Lisbon, Portugal. The product will initially be available in the European Union and a few selected markets.
www.ophtec.com
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.